Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Lactobacillus Quadruple Live Capsule in Bacterial Vaginosis
CTR20220546Phase 2Completed
- Sponsor
- Sichuan Yanyang Biotechnology
- Start
- Mar 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of quadrivalent Lactobacillus vaginal live capsule in bacterial vaginosis (BV), sponsored by Sichuan Yanyang Biotechnology. Started Mar 2022; status: completed.
02
Drugs
quadrivalent Lactobacillus vaginal live capsule
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20220546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220546.